November is Clostridium difficile Awareness Month . The C. diff foundation says over 41 individuals lose their life to a Clostridium difficile infection (CDI) in the United States of America alone every day — It has no boundaries — It can be acquired by anyone – at any location and at any age.
Infectious disease physician and returning expert guest, Steven LaRosa, MD joined to to discuss several aspects of CDI to include diagnosis, treatment and prevention. Fecal microbiota transplantation (FMT), new treatments in the pipeline and the future of vaccines were examined.
- Tickborne diseases: Laboratory diagnosis and treatment
- Sepsis: An interview with Steven LaRosa, MD
- Antibiotic stewardship: A look at penicillin allergies
- Infectious disease ‘pearls’: Treatment and diagnostics
- Clostridium difficile infection primary risk factor is outpatient antibiotics: Study
- Zinplava receives FDA approval to reduce recurrence of Clostridium difficile infection
- Clostridium Difficile Vaccine Candidate shows promising results in Phase II trials
- Pfizer’s Clostridium difficile vaccine candidate gets FDA Fast Track designation
- Specific Gut Flora Identified For Treating C. Difficile
- Treating recurrent C. diff with freeze-dried FMT: An interview with Dr Herbert DuPont